Market Trends
3 articles on Market Trends, written by Shotlee and medically reviewed for clinical accuracy.
GLP-1 Medications Fuel Surge in Meal Replacement Market
The global GLP-1 meal replacement market is experiencing explosive growth, projected to reach USD 10.9 billion by 2036. This surge is directly linked to the increasing adoption of GLP-1 medications like semaglutide and tirzepatide, alongside a growing consumer preference for convenient, nutrient-dense, and high-protein nutrition solutions designed to support weight management and reduced-appetite lifestyles.
7 min read
Semaglutide Generics: Spain Cuts Ozempic Costs
Ozempic and Wegovy have transformed weight management, but high costs limit access. A Spanish company is now manufacturing generic semaglutide, poised to slash prices as patents expire. This guide explores the implications for patients seeking affordable GLP-1 therapy.
4 min read
GLP-1's Impact: Forecasting the Food and Beverage Sector in 2026
The increasing use of GLP-1 drugs is reshaping the food and beverage industry. Circana's research highlights how retailers and manufacturers can adapt to meet the evolving needs of health-conscious consumers.
6 min read